retatrutide news recency 3 New Phase data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Today, we shared new data

FGFR4/1, fibroblast growth factor receptor4/1

It is difficult to distinguish symptoms from FDA-approved and compounded products, Basina noted

Unlike men who may see testosterone suppression, women often experience disrupted menstrual cycles due to the caloric deficit and rapid body composition changes

The long-term effects of tirzepatide on diabetic retinopathy and diabetic neuropathy remain a topic of considerable debate

Author / review note Reviewed by the FormBlends Medical Team

Eye problems Rapid improvement in blood sugar may temporarily worsen diabetic retinopathy, an eye condition related to type 1 and type 2 diabetes